MII IG Kerndatensatz-Modul Molekulares Tumorboard
2026.0.0 - release Unknown region code '276'

MII IG Kerndatensatz-Modul Molekulares Tumorboard, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-molekulares-tumorboard/ and changes regularly. See the Directory of published versions

Example MedicationRequest: Trastuzumab deruxtecan

MII EX MTB Empfehlung Priorität: 3

MII EX MTB Empfehlung Evidenzgraduierung: m1B

MII EX MTB Empfehlung Publikation: http://www.ncbi.nlm.nih.gov/pubmed/35665782

MII EX MTB Empfehlung Publikation: http://www.ncbi.nlm.nih.gov/pubmed/37870536

MII EX MTB Empfehlung Publikation: http://doi.org/10.1200/JCO.2023.41.17_suppl.LBA3000

status: Draft

intent: Proposal

medication: Trastuzumab deruxtecan

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

authoredOn: 2023-03-28

reasonReference: Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet